Cellebrite DI Ltd. (CLBT) Market Cap & Valuation Ratios
Cellebrite DI Ltd. (CLBT) has a market cap of $3.0B, a trailing P/E of 52.6 and a price-to-sales ratio of 6.4, with earnings according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
CLBTCellebrite DI Ltd.Follow CLBT — free
—
Price chart with a free account
- Market cap
- 3.0B
- P/E TTM
- 52.6
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 12 Nov, in 19 days
Peers
software - application · nearest by market cap · trailing 12 months| Company | Mkt cap, $B | P/E | EV/Sales | EV/EBITDA | FCF yield | Rev. growth | Op. margin | ROIC |
|---|---|---|---|---|---|---|---|---|
| CLBT | 3.0 | 52.6 | 5.8 | 35.2 | 4.8% | +19% | 14% | 13% |
| NATL | 3.5 | 18.3 | 1.3 | 7.5 | 3.6% | +4% | 11% | 15% |
| AGYS | 3.4 | 79.4 | 9.9 | 56.2 | 2.4% | +14% | 15% | 18% |
| SPSC | 3.3 | 44.5 | 4.1 | 25.9 | 6.0% | +10% | 13% | 9% |
| ALRM | 3.1 | 28.4 | 3.0 | 18.5 | 5.9% | +9% | 13% | 12% |
| VIA | 3.0 | — | 5.4 | — | -1.6% | +29% | -18% | -31% |
| BULL | 3.0 | — | 3.5 | 43.8 | 1.1% | +48% | 9% | 7% |
| PTRN | 2.9 | — | 0.8 | 41.6 | 3.7% | +44% | 1% | 11% |
| ASAN | 2.8 | — | 3.1 | — | 4.1% | +9% | -19% | — |
| KC | 2.5 | — | — | — | — | +31% | -8% | -8% |
| BLKB | 2.5 | 17.4 | 3.2 | 11.7 | 11.0% | +0.7% | 20% | 17% |
| Median of these 10 | 28.4 | 3.2 | 25.9 | 3.7% | +12% | 10% | 11% |
P/E 52.6 vs. a peer median of 28.4; EV/Sales 5.8 vs. 3.2. CLBT's own P/E sits at the 88th percentile of its history.
Growth vs. price
each dot a company · hover or tap for valuesVIA and BULL and PTRN and ASAN and KC have no P/E (earnings not positive) and are left out · hover or tap a dot for values.
Cellebrite DI Ltd. — questions
- What is Cellebrite DI Ltd.'s market cap?
- $3.0B.
- What is Cellebrite DI Ltd.'s P/E ratio?
- 52.6 on trailing twelve-month earnings to 2026-06-30.
- What is Cellebrite DI Ltd.'s price-to-sales ratio?
- 6.4.
Every figure on this page comes from Cellebrite DI Ltd.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.